A carregar...
Publicação
Entrada de biossimilares no mercado: o impacto na indústria farmacêutica e nos profissionais de saúde
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 509.33 KB | Adobe PDF |
Orientador(es)
Resumo(s)
O objectivo desta revisão bibliográfica consistiu em pesquisar e reunir informação sobre os biossimilares, mais especificamente o efeito da sua entrada no mercado farmacêutico e qual a opinião dos profissionais de saúde, nomeadamente os médicos, sobre esta nova alternativa terapêutica.
Este trabalho surgiu da análise da informação mais actual e disponível sobre o tema, obtida através de pesquisas bibliográficas em motores de busca, tais como, pubmed e Ovid. Outra fonte de informação importante foi o Ciclo de Conferências do INFARMED “ Medicamentos Biossimilares – Presente e Futuro”.
Os biossimilares têm um impacto importante na redução de custos com as terapêuticas biológicas, melhorando o acesso dos doentes a estas terapêuticas avançadas e originando poupanças substanciais aos sistemas de saúde.
Contudo, as reduções de custo da utilização dos biossimilares foram inferiores ao esperado e existe alguma insegurança em prescrever estes medicamentos, devido à pouca experiência na utilização de biossimilares e também ao receio de casos de imunogenicidade, que são possíveis a todos os medicamentos biológicos
The purpose of this work was to search and gather information concerning biosimilars, specifically the effect of its penetration in the pharmaceutical market, and to learn the opinion of the clinics and healthcare professionals regarding this new alternative treatment. An analysis was performed with the most recent information on the subject, through the bibliographic research in search engines such as pubmed and Ovid. Other important source of information on the subject was the cycle of conferences from INFARMED “Medicamentos Biossimilares: Presente e Futuro”. The biosimilars have an important role in cost reduction of biological therapeutics, as they improve the patients’ access to advanced therapeutics while instigating substantial savings to the health system. Nonetheless, the cost reduction biosimilars use were less than expected, when comparing with generic medicines. Furthermore, there is some insecurity in prescribing such medication due to the lack of experience in their use, and also the possibility of immunogenicity cases, which are common to all biological medicines.
The purpose of this work was to search and gather information concerning biosimilars, specifically the effect of its penetration in the pharmaceutical market, and to learn the opinion of the clinics and healthcare professionals regarding this new alternative treatment. An analysis was performed with the most recent information on the subject, through the bibliographic research in search engines such as pubmed and Ovid. Other important source of information on the subject was the cycle of conferences from INFARMED “Medicamentos Biossimilares: Presente e Futuro”. The biosimilars have an important role in cost reduction of biological therapeutics, as they improve the patients’ access to advanced therapeutics while instigating substantial savings to the health system. Nonetheless, the cost reduction biosimilars use were less than expected, when comparing with generic medicines. Furthermore, there is some insecurity in prescribing such medication due to the lack of experience in their use, and also the possibility of immunogenicity cases, which are common to all biological medicines.
Descrição
Trabalho Final de Mestrado Integrado, Ciências Farmacêuticas, Universidade de Lisboa, Faculdade de Farmácia, 2013
Palavras-chave
Biotecnologia Biossimilares Medicamentos biológicos Mercado farmacêutico Mestrado Integrado - 2013